Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.

doi:10.1111/j.1537-2995.2009.02395.x

Skip navigation

Results
This Paper

To show you the PDF, we need your affiliation

(Don't worry, you'll only have to do this once)

Affiliation:

Cancel

Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.

Jie J Yang, Li L Gao, Yan Y Liu, Yana Y Ren, Rufeng R Xie, Huahua H Fan and Kaicheng K Qian crossref 50(2):407-17 1 Feb 2010 PMID 19788510

Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for preventing GVHD after allogeneic bone marrow transplantation (BMT).

DOI: 10.1111/j.1537-2995.2009.02395.x
Version: za2963e q8za2 q8zbe q8zca q8zda q8zea q8zfe q8zg0

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.

paper

citation

Log in to Pubget.